Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report studies the Urology Drugs market. Urology drugs is the branch of drugs that focuses on diseases of the male and female urinary-tract system and the male reproductive organs.
The report details the trend, potential and market size of Urology Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Urology Drugsmarket, defines the market attractiveness level of Urology Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Urology Drugs industry, describes the types of Urology Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Urology Drugs market and the development prospects and opportunities of Urology Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Urology Drugs market in Chapter 13.
By Player:
Endo
Astellas
GP Pharm
Tolmar
By Type:
? (alpha)-blockers
5 ?-reductase inhibitors
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Urology Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Urology Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Urology Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Urology Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Urology Drugs Market Analysis and Outlook to 2022
-
7.1 Global Urology Drugs Consumption (2017-2022)
-
7.2 United States Urology Drugs Consumption (2017-2022)
-
7.3 Europe Urology Drugs Consumption (2017-2022)
-
7.4 China Urology Drugs Consumption (2017-2022)
-
7.5 Japan Urology Drugs Consumption (2017-2022)
-
7.6 India Urology Drugs Consumption (2017-2022)
-
7.7 South Korea Urology Drugs Consumption (2017-2022)
8 Region and Country-wise Urology Drugs Market Analysis and Outlook to 2028
-
8.1 Global Urology Drugs Consumption Forecast (2022-2028)
-
8.2 United States Urology Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Urology Drugs Consumption Forecast (2022-2028)
-
8.4 China Urology Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Urology Drugs Consumption Forecast (2022-2028)
-
8.6 India Urology Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Urology Drugs Consumption Forecast (2022-2028)
9 Global Urology Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Urology Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ? (alpha)-blockers Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 5 ?-reductase inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Urology Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Urology Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Urology Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ? (alpha)-blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 5 ?-reductase inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Urology Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Urology Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Urology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Urology Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Urology Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Urology Drugs Market Competitive Analysis
-
14.1 Endo
-
14.1.1 Endo Company Details
-
14.1.2 Endo Urology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Endo Urology Drugs Product and Service
-
14.2 Astellas
-
14.2.1 Astellas Company Details
-
14.2.2 Astellas Urology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astellas Urology Drugs Product and Service
-
14.3 GP Pharm
-
14.3.1 GP Pharm Company Details
-
14.3.2 GP Pharm Urology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GP Pharm Urology Drugs Product and Service
-
14.4 Tolmar
-
14.4.1 Tolmar Company Details
-
14.4.2 Tolmar Urology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Tolmar Urology Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Urology Drugs
-
Figure Urology Drugs Picture
-
Table Global Urology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Urology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Urology Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Urology Drugs Consumption by Country (2017-2022)
-
Figure United States Urology Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Urology Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Urology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Urology Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Urology Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Urology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Urology Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Urology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Urology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Urology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Urology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Urology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Urology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ? (alpha)-blockers Consumption and Growth Rate (2017-2022)
-
Figure Global 5 ?-reductase inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global ? (alpha)-blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 5 ?-reductase inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Urology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Urology Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Endo (Foundation Year, Company Profile and etc.)
-
Table Endo Urology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo Urology Drugs Product and Service
-
Table Astellas (Foundation Year, Company Profile and etc.)
-
Table Astellas Urology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Urology Drugs Product and Service
-
Table GP Pharm (Foundation Year, Company Profile and etc.)
-
Table GP Pharm Urology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GP Pharm Urology Drugs Product and Service
-
Table Tolmar (Foundation Year, Company Profile and etc.)
-
Table Tolmar Urology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tolmar Urology Drugs Product and Service
-
